Enhanced Recovery After Laparoscopic Sleeve Gastrectomy - a Randomised Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 106
- Locations
- 2
- Primary Endpoint
- Length of Hospital Stay
Study Overview
Brief Summary
The investigators wish to standardise and optimise perioperative care for consecutive patients undergoing laparoscopic sleeve gastrectomy for weight loss. The investigators will compare patients under a standardised perioperative care program to patients who undergo routine perioperative in our hospital and determine whether patients who had optimised perioperative care went home earlier and had fewer complications.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 20 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients undergoing laparascopic sleeve gastrectomy for weight loss by surgeons who have agreed to participate in the study
- •Surgery occurs at Manukau Surgery Centre
Exclusion Criteria
- •Surgery not occuring in Manukau Superclinic
Outcomes
Primary Outcomes
Length of Hospital Stay
Time Frame: day of discharge
The trial intends to investigate whether median length of hospital stay for patients under a standardised optimised perioperative care program is less than patients who have routine perioperative care that undergo the same operation.
Secondary Outcomes
- Complications(30 days)
- Readmission rates(30 days)
- Postoperative fatigue(Baseline and postoperative days 1, 7 and 14)
- Compliance to the ERAS protocol(through to day 1 postoperatively)
Investigators
SACS
Professor Andrew G. Hill
University of Auckland, New Zealand